tiprankstipranks
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market

Compare Belite Bio, Inc. ADR (BLTE) vs. Competitors

59 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Belite Bio, Inc. ADR
$172.76
$6.80B
-69.12
195.22%
7 Buy
0 Hold
0 Sell
Strong Buy
Denali Therapeutics
$19.23
$3.05B
-5.65
53.84%
13 Buy
1 Hold
0 Sell
Strong Buy
Kiniksa Pharmaceuticals
$47.08
$3.60B
51.87
152.44%
6 Buy
0 Hold
0 Sell
Strong Buy
Beam Therapeutics
$27.43
$2.79B
-34.27
87.49%
11 Buy
1 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$28.89
$1.67B
13.56
-0.34%
4 Buy
3 Hold
1 Sell
Moderate Buy
Centessa Pharmaceuticals
$39.48
$5.89B
-17.18
250.31%
2 Buy
8 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BLTE
Belite Bio, Inc. ADR
172.76
114.15
194.76%
DNLI
Denali Therapeutics
19.23
5.96
44.91%
KNSA
Kiniksa Pharmaceuticals
47.08
26.39
127.55%
BEAM
Beam Therapeutics
27.43
10.43
61.35%
HRMY
Harmony Biosciences Holdings
28.89
-0.64
-2.17%
CNTA
Centessa Pharmaceuticals
39.48
27.54
230.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts